Coexistence of beta-thalassemia and hereditary hemochromatosis in homozygosity: a possible synergic effect?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 19373593)

Published in Hemoglobin on January 01, 2009

Authors

Nenad Bukvic1, Filomena Sportelli, Francesco Sessa, Vittoria Longo, Maria Grazia Roberti, Rosa Santacroce, Maurizio Margaglione

Author Affiliations

1: Genetica Medica, Dipartimento di Scienze Biomediche, Universita degli Studi di Foggia, v. le Pinto, Foggia, Italia. nenadbukvic@virgilio.it

Articles by these authors

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood (2004) 4.70

Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol (2006) 2.70

Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance. Liver Int (2013) 2.07

Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol (2004) 1.62

Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation: an 8-year longitudinal comparison with mitral valve replacement and inherited thrombophilia. Thromb Haemost (2005) 1.50

Mutation analysis in hyperphenylalaninemia patients from South Italy. Clin Biochem (2013) 1.44

Clinical relevance of inherited thrombophilia in implantation failure: who needs to be screened? Haematologica (2003) 1.42

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis. Blood (2012) 1.31

Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol (2007) 1.13

Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin. Haematologica (2004) 1.12

Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention. Am J Hematol (2009) 1.11

The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression. Nephrol Dial Transplant (2002) 1.08

Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths. Haematologica (2002) 0.99

The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia. Blood Coagul Fibrinolysis (2006) 0.94

Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene. Mol Vis (2009) 0.93

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica (2008) 0.91

Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications. Thromb Haemost (2009) 0.91

Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. Hum Mutat (2005) 0.90

Inherited platelet disorders: thrombocytopenias and thrombocytopathies. Blood Transfus (2009) 0.89

Clinical utility of screening for CALR gene exon 9 mutations in patients with splanchnic venous thrombosis. Thromb Haemost (2015) 0.89

Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview. Clin Appl Thromb Hemost (2009) 0.89

Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA). Mol Genet Metab (2008) 0.87

Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost (2002) 0.86

Occurrence of the JAK2 V617F mutation in the Budd-Chiari syndrome. Blood Coagul Fibrinolysis (2008) 0.85

PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant (2003) 0.85

Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. Atherosclerosis (2009) 0.85

Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol Aging (2003) 0.84

Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2. Fertil Steril (2008) 0.84

Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strength. Thromb Haemost (2002) 0.84

Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis (2008) 0.83

Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Haematologica (2002) 0.83

Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc Dis (2003) 0.83

Gene polymorphisms and sport attitude in Italian athletes. Genet Test Mol Biomarkers (2011) 0.83

The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene. Invest Ophthalmol Vis Sci (2011) 0.83

Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis. Thromb Res (2011) 0.83

The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: results of a multicentre prospective study. Nephrol Dial Transplant (2004) 0.83

Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group. Blood Coagul Fibrinolysis (2006) 0.82

Congenital nephrotic syndrome of Finnish type: detection of new nephrin mutations and prenatal diagnosis in an Italian family. Prenat Diagn (2005) 0.82

A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11). Cancer Genet Cytogenet (2004) 0.82

A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. Cancer Genet Cytogenet (2004) 0.82

A novel mutation of gene CBFA1/RUNX2 in cleidocranial dysplasia. Ann Clin Lab Sci (2007) 0.82

TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings. Biomed Res Int (2013) 0.82

Mutational spectrum of the c1 inhibitor gene in a cohort of Italian patients with hereditary angioedema: description of nine novel mutations. Ann Hum Genet (2014) 0.81

High rates of psychosis for black inpatients in Padua and Montreal: different contexts, similar findings. Soc Psychiatry Psychiatr Epidemiol (2010) 0.81

A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis. Blood (2007) 0.81

The haplotype M2 within the ANXA5 gene is independently associated with the occurrence of deep venous thrombosis. Thromb Haemost (2010) 0.81

Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants. Prenat Diagn (2006) 0.81

Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study. Thromb Haemost (2004) 0.81

Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation. Thromb Res (2013) 0.81

Rescue of activated protein C-resistance phenotype by cis-acting factor V Gly2032Asp mutation. Haematologica (2004) 0.81

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors. Blood Rev (2008) 0.81

Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost (2004) 0.81

Role of the M2 haplotype within the annexin A5 gene in the occurrence of pregnancy-related venous thromboembolism. Am J Obstet Gynecol (2010) 0.80

Pyrosequencing for detection of mutations in the connexin 26 (GJB2) and mitochondrial 12S RNA (MTRNR1) genes associated with hereditary hearing loss. Hum Mutat (2002) 0.80

The risk of occurrence of venous thrombosis: focus on protein Z. Thromb Res (2011) 0.80

A novel G-to-A mutation in the intron-N of the protein S gene leading to abnormal RNA splicing in a patient with protein S deficiency. Haematologica (2003) 0.79

Detection of new deletions in a group of Italian patients with Hemophilia A by multiplex ligation-dependent probe amplification. Genet Test Mol Biomarkers (2009) 0.79

Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology. Clin Chem (2002) 0.79

Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. Haemophilia (2014) 0.79

A novel mutation in human ether-a-go-go-related gene, alanine to proline at position 490, found in a large family with autosomal dominant long QT syndrome. Am J Cardiol (2007) 0.79

Homozygosity by descent of a 3Mb chromosome 17 haplotype causes coinheritance of Glanzmann thrombasthenia and primary ciliary dyskinesia. Blood (2013) 0.79

Fatal pulmonary thromboembolism. A retrospective autopsy study: searching for genetic thrombophilias (Factor V Leiden (G1691A) and FII (G20210A) gene variants) and dating the thrombus. Forensic Sci Int (2011) 0.79

McKusick-Kaufman or Bardet-Biedl syndrome? A new borderline case in an Italian nonconsanguineous healthy family. Indian J Hum Genet (2011) 0.78

A new method for determination of plasma homocystine by isotope dilution and electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.78

Characterization of hemoglobin bassett (alpha94Asp-->Ala), a variant with very low oxygen affinity. Am J Hematol (2004) 0.78

Protein Z levels and unexplained fetal losses. Fertil Steril (2004) 0.78

Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians. Atherosclerosis (2002) 0.78

Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet (2007) 0.78

Homocysteine levels in amniotic fluid. Relationship with birth-weight. Thromb Haemost (2006) 0.78

Genetic basis of thrombosis. Clin Chem Lab Med (2010) 0.78

Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases. Genes Chromosomes Cancer (2003) 0.77

Inherited thrombophilia and gestational vascular complications. Best Pract Res Clin Haematol (2003) 0.77

A new case of combined factor V and factor VIII deficiency further suggests that the LMAN1 M1T mutation is a frequent cause in Italian patients. Blood Coagul Fibrinolysis (2007) 0.77

A rapid method for the quantification of the enantiomers of Warfarin, Phenprocoumon and Acenocoumarol by two-dimensional-enantioselective liquid chromatography/electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.77

Protein Z g-42a variant and the risk of pregnancy-related venous thromboembolism in a cohort of Italian patients. Thromb Res (2009) 0.77

Glanzmann's thrombasthenia: modulation of clinical phenotype by alpha2C807T gene polymorphism. Haematologica (2003) 0.76

Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy? Hypertens Pregnancy (2003) 0.76

Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations. Haematologica (2002) 0.76

Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow. Thromb Res (2009) 0.76

De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema. J Allergy Clin Immunol (2013) 0.76

Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation. Thromb Haemost (2006) 0.76

Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation. Thromb Haemost (2008) 0.76

Fetal sex identification in maternal plasma by means of short tandem repeats on chromosome x. Ann N Y Acad Sci (2008) 0.76

Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis. Eur J Gastroenterol Hepatol (2008) 0.75

Family history of VTE: an easy tool to score the individual risk. Thromb Haemost (2013) 0.75

Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family. Eur J Haematol (2012) 0.75

Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta. Thromb Res (2008) 0.75

How to handle low-molecular-weight heparins in patients with decreased renal function: an open issue. Intern Emerg Med (2008) 0.75